Xylo Technologies Ltd (XYLO)

Market Cap	6.35M
Revenue (ttm)	29.86M
Net Income (ttm)	-6.03M
Shares Out	1.28M
EPS (ttm)	-8.10
PE Ratio	n/a
Forward PE	12.40
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,965
Open	5.100
Previous Close	5.130
Day's Range	4.880 - 5.120
52-Week Range	2.700 - 6.667
Beta	0.15
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 22, 2025

About XYLO

Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Great Britain, Israel, Canada, Asia, and internationally. It operates through Corporate, Online Advertising & Internet Traffic Routing, Online Event Management, and Real-estate and Electronics segments. The company offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. It also provides digital advertising platform; and operates online stor...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 38
• Stock Exchange: NASDAQ
• Ticker Symbol: XYLO
• Website: https://www.medigus.com

Financial Performance

In 2024, Xylo Technologies's revenue was $29.86 million, a decrease of -67.45% compared to the previous year's $91.72 million. Losses were -$6.03 million, -62.39% less than in 2023.

Financial numbers in USD